Washington, D.C. – MedStar Heart & Vascular Institute has enrolled its first patient to a clinical trial to determine whether cardiac stem cells reduce inflammation enough to improve heart function in patients with heart failure severe enough to require a left ventricular assist device, or LVAD. STEMVAD is a randomized, double-blinded, placebo-controlled study that will assess the effects of multiple intravenous administration of CardioCell’s proprietary mesenchymal stem cells (MSCs). It is expected to enroll 30 patients. The STEMVAD trial is the next step in MedStar Heart & Vascular Institute’s earlier research that discovered “one of the major problems in heart…

Read More

Washington, D.C. – The 5E Medical Oncology/Hematology Unit at MedStar Washington Hospital Center has received the prestigious AMSN PRISM Award®, an honor recognizing exceptional nursing practice, leadership, and outcomes in hospital medical-surgical units. The award, which stands for “Premier Recognition In the Specialty of Med-Surg,” is the first of its kind honoring med-surg nursing units in the United States and internationally. It is co-sponsored by the Academy of Medical-Surgical Nurses (AMSN) and the Medical-Surgical Nursing Certification Board (MSNCB). The award is given to outstanding acute care/med-surg units or adult/pediatric units classified as med-surg. Andrea Melendez, MSN, RN, National Secretary of AMSN,…

Read More

Only Heart Program Nationally Ranked in the Washington Region by U.S. News

Read More